Yahoo Finance IVERIC bio, Inc. (NASDAQ:ISEE) insiders are still down US$16k after purchasing last year, recent gain helped regain some losses
Insiders who bought US$50k worth of IVERIC bio, Inc. (NASDAQ:ISEE) stock in the last year recovered part of their losses as the stock rose by 5.2% last week. The purchase, however, has proven to be a pricey bet, with losses currently totalling US$16k.
While insider transactions are not the most important thing when it comes to long-term investing, logic dictates you should pay some attention to whether insiders are buying or selling shares.
See our latest analysis for IVERIC bio
IVERIC bio Insider Transactions Over The Last Year
In the last twelve months, the biggest single purchase by an insider was when Senior VP & Chief Commercial Officer Christopher Simms bought US$50k worth of shares at a price of US$16.30 per share. That means that even when the share price was higher than US$10.98 (the recent price), an insider wanted to purchase shares. It's very possible they regret the purchase, but it's more likely they are bullish about the company. To us, it's very important to consider the price insiders pay for shares. It is encouraging to see an insider paid above the current price for shares, as it suggests they saw value, even at higher levels. Christopher Simms was the only individual insider to buy during the last year.
You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
IVERIC bio is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.
Does IVERIC bio Boast High Insider Ownership?
Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. We usually like to see fairly high levels of insider ownership. From our data, it seems that IVERIC bio insiders own 0.7% of the company, worth about US$8.9m. Overall, this level of ownership isn't that impressive, but it's certainly better than nothing!
So What Does This Data Suggest About IVERIC bio Insiders?
It doesn't really mean much that no insider has traded IVERIC bio shares in the last quarter. However, our analysis of transactions over the last year is heartening. While we have no worries about the insider transactions, we'd be more comfortable if they owned more IVERIC bio stock. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. When we did our research, we found 4 warning signs for IVERIC bio (1 is potentially serious!) that we believe deserve your full attention.
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
